JASON KEINER: Open Payments
NPI 1700236759 · SPRINGFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$341 in 15 payments from 10 companies in 2025. Trend: 2023 $849 · 2024 $1,121 · 2025 $341
Food & beverage: $341
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Novo Nordisk Inc | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Eisai Inc. | 1 | $30 |
| UCB, Inc. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| ACADIA Pharmaceuticals Inc | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: VRAYLAR, REXULTI, TRELEGY ELLIPTA, Leqembi, Nayzilam, INGREZZA, Ozempic, NUPLAZID.
Industry payments across PA — which companies pay providers there.
